EirGenix Revenue

In the year 2024, EirGenix had annual revenue of 1.01B TWD, down -1.34%. EirGenix had revenue of 294.64M in the quarter ending December 31, 2024, a decrease of -35.47%.

Revenue

1.01B

Revenue Growth

-1.34%

P/S Ratio

18.62

Revenue / Employee

n/a

Employees

n/a

Market Cap

18.78B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.01B	-13.69M	-1.34%
Dec 31, 2023	1.02B	-458.36M	-30.95%
Dec 31, 2022	1.48B	-216.34M	-12.75%
Dec 31, 2021	1.70B	625.52M	58.36%
Dec 31, 2020	1.07B	595.75M	125.14%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	9.73B
Caliway Biopharmaceuticals	44.43M
Bora Pharmaceuticals Co., LTD.	19.25B
Lotus Pharmaceutical	18.58B
Oneness Biotech	117.93M
Polaris Group	107.00M
Lumosa Therapeutics	39.15M
Pegavision	6.82B

Revenue Rankings